Cease ye specific potions, lest ye desire a mighty relapse of the scurvy known as Multiple Scurvy! Arrr!
2024-03-28
Arrr, ye scallywags! Beware of sailin' into rough waters after stoppin' the likes of natalizumab and fingolimod for MS. The risk of a relapse be as fierce as a kraken in these older patients. Watch yer step on the high seas of medicine, lest ye be caught in a mighty storm!
Arrr mateys, listen up ye scurvy dogs! A new study be showin' that older patients with the dreaded nonactive MS be facin' a dangerous risk of relapse if they be stoppin' their natalizumab or fingolimod treatment. That be a treacherous path to sail, so heed this warnin'!The researchers from the Medscape Medical News be findin' that these older patients be facin' a significant increase in the risk of havin' a relapse once they be stoppin' their treatment. This be a serious matter, me hearties, so don't be takin' it lightly!
So, me fellow pirates with MS, be sure to consult with yer trusted healthcare provider before makin' any decisions about discontinuin' yer treatment. It be better to be safe than sorry, lest ye find yerself in troubled waters with a flare-up of yer MS. Take heed of this warnin', me mateys, and may ye sail smoothly on the seas of health and wellness!